chr10-93061274-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_183374.3(CYP26C1):ā€‹c.11G>Cā€‹(p.Trp4Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000316 in 1,583,834 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.000026 ( 0 hom., cov: 33)
Exomes š‘“: 7.0e-7 ( 0 hom. )

Consequence

CYP26C1
NM_183374.3 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.762
Variant links:
Genes affected
CYP26C1 (HGNC:20577): (cytochrome P450 family 26 subfamily C member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This enzyme is involved in the catabolism of all-trans- and 9-cis-retinoic acid, and thus contributes to the regulation of retinoic acid levels in cells and tissues. This gene is adjacent to a related gene on chromosome 10q23.33. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2859115).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CYP26C1NM_183374.3 linkuse as main transcriptc.11G>C p.Trp4Ser missense_variant 1/6 ENST00000651965.1 NP_899230.2 Q6V0L0

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CYP26C1ENST00000651965.1 linkuse as main transcriptc.11G>C p.Trp4Ser missense_variant 1/6 NM_183374.3 ENSP00000498424.1 Q6V0L0
CYP26C1ENST00000624358.3 linkuse as main transcriptn.11G>C non_coding_transcript_exon_variant 1/62 ENSP00000485098.1 A0A096LNL5

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152156
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000519
AC:
1
AN:
192656
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
104988
show subpopulations
Gnomad AFR exome
AF:
0.0000899
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
6.98e-7
AC:
1
AN:
1431678
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
709652
show subpopulations
Gnomad4 AFR exome
AF:
0.0000302
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152156
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
4
AN XY:
74332
show subpopulations
Gnomad4 AFR
AF:
0.0000965
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000302

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 24, 2024The c.11G>C (p.W4S) alteration is located in exon 1 (coding exon 1) of the CYP26C1 gene. This alteration results from a G to C substitution at nucleotide position 11, causing the tryptophan (W) at amino acid position 4 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.35
T
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.13
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.62
T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.29
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.9
L
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-2.9
D
REVEL
Benign
0.23
Sift
Benign
0.18
T
Sift4G
Uncertain
0.053
T
Polyphen
0.039
B
Vest4
0.49
MutPred
0.55
Gain of disorder (P = 1e-04);
MVP
0.86
MPC
0.067
ClinPred
0.053
T
GERP RS
4.2
Varity_R
0.16

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1316338360; hg19: chr10-94821031; API